Stay updated with breaking news from Nasdaq Sln. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the target of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 125,100 shares, a growth of 24.0% from the July 31st total of 100,900 shares. Based on an average daily volume of 57,800 shares, […]
Chardan Capital restated their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a report released on Thursday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Morgan Stanley restated an overweight rating and issued a $20.00 target price on shares of Silence Therapeutics in a […]
Chardan Capital reaffirmed their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $26.00 price target on the stock. Separately, Morgan Stanley reissued an overweight rating and set a $20.00 price target on shares of Silence Therapeutics in […]
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 100,900 shares, an increase of 41.3% from the July 15th total of 71,400 shares. Currently, 0.4% of the company’s shares are short sold. […]
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 100,900 shares, a growth of 41.3% from the July 15th total of 71,400 shares. Based on an average daily volume of 69,100 shares, […]